Aspire Biopharma Holdings, Inc. (ASBP)
Develops fast-dissolving tablets that deliver aspirin and other drugs under the tongue
$7.25+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-49.7%
The outlook
ASBP is trading near the lower end of its 52-week range, though it sits above both its 50- and 200-day moving averages. Analyst coverage appears limited. The current data leans modestly bullish overall.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range20% of the way from its 52-week low to high
Market cap
$9.4M
52-wk high
$35.00
52-wk low
$0.11
50-day avg
$6.06
200-day avg
$4.52
Trailing P/E
—